DUBLIN, April 9, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/cdqkxc/cervical_cancer) has announced the addition of the "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.
Cervical cancer test market is dominated by United States in 2013. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.
A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.
The report titled "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report have been studied from 3 viewpoints.
Key Topics Covered:
1. Executive Summary
2. Worldwide Cervical Cancer Test (Screening) Population & Forecast
3. Worldwide Cervical Cancer Test (Screening) Market & Forecast
4. Worldwide Cervical Cancer Test (Screening) Population Share, Market Share & Forecast
5. United Kingdom - Cervical Cancer Test Analysis
6. France - Cervical Cancer Test Analysis
7. Germany - Cervical Cancer Test Analysis
8. Italy - Cervical Cancer Test Analysis
9. Spain - Cervical Cancer Test Analysis
10. Sweden - Cervical Cancer Test Analysis
11. Switzerland - Cervical Cancer Test Analysis
12. Norway - Cervical Cancer Test Analysis
13. Netherlands - Cervical Cancer Test Analysis
14. United States - Cervical Cancer Test Analysis
15. Canada - Cervical Cancer Test Analysis
16. Japan - Cervical Cancer Test Analysis
17. South Korea - Cervical Cancer Tests Analysis
18. Singapore - Cervical Cancer Tests Analysis
19. Malaysia - Cervical Cancer Test Analysis
20. Australia - Cervical Cancer Test Analysis
21. India - Cervical Cancer Test Analysis
22. China - Cervical Cancer Test Analysis
23. Thailand - Cervical Cancer Test Analysis
24. Indonesia - Cervical Cancer Test Analysis
25. Cervical Cancer Test Market Growth Drivers
26. Challenges in Cervical Cancer Test Market
Countries Covered:
For more information visit http://www.researchandmarkets.com/research/cdqkxc/cervical_cancer
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article